NIH Guide: Weekly Index for June 21, 2024

Funding Opportunities

• CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
  (PAR-24-030)
  National Institute of Neurological Disorders and Stroke
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
  (PAR-24-221)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
  (PAR-24-222)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Not Applicable
• Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
  (PAR-24-238)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Office of Nutrition Research
  Office of Research on Women's Health
  Office of Dietary Supplements
  Application Receipt Date(s): Multiple dates, see announcement.
• Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
  (PAR-24-239)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Office of Nutrition Research
  Office of Research on Women's Health
  Office of Dietary Supplements
  Application Receipt Date(s): Multiple dates, see announcement.
• Animal and Veterinary Innovation Centers
  (PAR-24-251)
  Food and Drug Administration
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
  (RFA-AI-24-029)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed)
  (RFA-AT-24-010)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Dietary Supplements
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)
  (RFA-DA-25-044)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
  (RFA-DA-25-045)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
  (RFA-MD-24-009)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.